FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Noqdirna 50microgram oral lyophilisates (Ferring Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Noqdirna 25microgram oral lyophilisates (Ferring Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Triamcinolone 0.1% oromucosal paste (Drug Tariff Special Order) 5 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely aspirin 300 milligram/1 each conventional release rectal suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely aspirin 150 milligram/1 each conventional release rectal suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aspirin 150mg suppositories (Martindale Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aspirin 150mg suppositories 10 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aspirin 300mg suppositories (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aspirin 300mg suppositories (The Boots Company) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aspirin 150mg suppositories (Colorama Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aspirin 150mg suppositories (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aspirin 300mg suppositories 10 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aspirin 300mg suppositories (Colorama Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aspirin 150mg suppositories (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aspirin 300mg suppositories (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aspirin 300mg suppositories (Martindale Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aspirin 300mg suppositories (Colorama Pharmaceuticals Ltd) 10 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aspirin 150mg suppositories (Martindale Pharmaceuticals Ltd) 10 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aspirin 150mg suppositories (Colorama Pharmaceuticals Ltd) 10 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aspirin 150mg suppositories (Unichem Plc) 10 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aspirin 300mg suppositories (Martindale Pharmaceuticals Ltd) 10 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aspirin 300mg suppositories (The Boots Company) 10 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aspirin 300mg suppositories (Unichem Plc) 10 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aspirin 150mg suppositories (A A H Pharmaceuticals Ltd) 10 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aspirin 300mg suppositories (A A H Pharmaceuticals Ltd) 10 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Potassium chloride 0.15% (potassium 10mmol/500ml) / Glucose 5% infusion 500ml bags (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium chloride 292.5mg/5ml (1mmol/ml) oral solution sugar free (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Potassium chloride 0.15% (potassium 10mmol/500ml) / Glucose 5% infusion 500ml bags 10 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Potassium chloride 0.15% (potassium 10mmol/500ml) / Glucose 5% infusion 500ml bags (A A H Pharmaceuticals Ltd) 10 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium chloride 292.5mg/5ml (1mmol/ml) oral solution sugar free (Alliance Healthcare (Distribution) Ltd) 100 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nalbuphine hydrochloride 10mg/mL injection solution 2mL ampule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nalbuphine 20mg/2ml solution for injection ampoules 10 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nubain 20mg/2ml solution for injection ampoules (Bristol-Myers Squibb Pharmaceuticals Limited) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nalbuphine 20mg/2ml solution for injection ampoules (Imported (Austria)) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nalbuphine 20mg/2ml solution for injection ampoules (Imported (Austria)) 10 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nubain 20mg/2ml solution for injection ampoules (Bristol-Myers Squibb Pharmaceuticals Limited) 10 ampoule 10 x 2ml ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ventra 20mg gastro-resistant capsules (Ethypharm UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ventra 40mg gastro-resistant capsules (Ethypharm UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg tablets (Teva UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 20mg tablets (Teva UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg/5ml oral solution (Teva UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ventra 20mg gastro-resistant capsules (Ethypharm UK Ltd) 28 capsule 4 x 7 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ventra 40mg gastro-resistant capsules (Ethypharm UK Ltd) 28 capsule 4 x 7 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg tablets (Teva UK Ltd) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 20mg tablets (Teva UK Ltd) 84 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg/5ml oral solution (Teva UK Ltd) 120 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Microdot Safety Pen hypodermic insulin needles for pre-filled / reusable pen injectors screw on 5mm/30gauge (Cambridge Sensors Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Microdot Safety Pen hypodermic insulin needles for pre-filled / reusable pen injectors screw on 5mm/30gauge (Cambridge Sensors Ltd) 100 needle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Phentolamine mesylate 10mg/mL injection solution 1mL ampule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Phentolamine 10mg/1ml solution for injection ampoules 5 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rogitine 10mg/1ml solution for injection ampoules (Alliance Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Phentolamine 10mg/1ml solution for injection ampoules (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Phentolamine 10mg/1ml solution for injection ampoules 1 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Phentolamine 10mg/1ml solution for injection ampoules (Special Order) 5 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rogitine 10mg/1ml solution for injection ampoules (Alliance Pharmaceuticals Ltd) 5 ampoule 5 x 1ml ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Phentolamine 10mg/1ml solution for injection ampoules (Special Order) 1 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Conestat alfa 2,100unit powder for solution for injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ruconest 2,100unit powder for solution for injection (Swedish Orphan Biovitrum Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Conestat alfa 2,100unit powder for solution for injection 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ruconest 2,100unit powder for solution for injection (Swedish Orphan Biovitrum Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 25,000units/5ml solution for injection ampoules (Panpharma UK Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 25,000units/5ml solution for injection ampoules (Panpharma UK Ltd) 10 ampoule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 40mg gastro-resistant capsules (Aristo Pharma GmbH) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 20mg gastro-resistant capsules (Aristo Pharma GmbH) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 40mg gastro-resistant capsules (Aristo Pharma GmbH) 28 capsule 2 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 20mg gastro-resistant capsules (Aristo Pharma GmbH) 28 capsule 2 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
LiquaMag GP (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution (Fontus Health Ltd) 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rupafin 10mg tablets (GlaxoSmithKline) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (Aspire Pharma Ltd) 30 tablet 2 x 15 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rupafin 10mg tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Carmustine 100mg powder and solvent for infusion vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely imatinib 100 milligram/1 each conventional release oral capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Imatinib 100mg capsules 120 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glivec 100mg capsules (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Carmustine 100mg powder and solvent for solution for infusion vials (Emcure Pharma UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Carmustine 100mg powder and solvent for solution for injection vials 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Imatinib 100mg capsules (Dr Reddy's Laboratories (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Carmustine 100mg powder and solvent for solution for injection vials 10 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Imatinib 100mg capsules 60 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glivec 100mg capsules (Novartis Pharmaceuticals UK Ltd) 120 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 10 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Carmustine 100mg powder and solvent for solution for infusion vials (Emcure Pharma UK Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Imatinib 100mg capsules (Dr Reddy's Laboratories (UK) Ltd) 60 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bilastine 20mg tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bilastine 20mg tablets 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ilaxten 20 mg tablets (A Menarini Pharma UK S.R.L.) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ilaxten 20 mg tablets (A Menarini Pharma UK S.R.L.) 30 tablet 3 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Caffeine 50mg tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Caffeine 50mg tablets 24 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Caffeine 50mg tablets 36 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Caffeine 50mg tablets 48 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Caffeine 50mg tablets 12 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Caffeine 50mg tablets 96 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pro Plus 50mg tablets (Bayer Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pro Plus 50mg tablets (Bayer Plc) 48 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pro Plus 50mg tablets (Bayer Plc) 96 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pro Plus 50mg tablets (Bayer Plc) 12 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 71 of 86 Next End

This concept is not in any reference sets

Back to Start